Rallybio’s Post

There are many shared challenges across regenerative medicine, stem cell biology, and cultivated meat production that offer opportunities for synergistic problem-solving. For example, regenerative medicine researchers could make important contributions to the challenges of scaling cellular material, understanding the molecular basis of cell differentiation and proliferation, stem cell biology, and scaffolding. That's why Elliot and I are very enthusiastic about collaborating with partners from different fields, including regenerative medicine and biomanufacturing. If you are attending ARMI's meeting or have ideas about intersection of regenerative medicine and cultivated meat please reach out to us! #altprotein #regenerativemedicine #stem #cultivatedmeat

Colorado BioScience Association's (CBSA) BioScience Colorado Magazine highlights Colorado startups working to save and change lives. In the article, "Leading Innovation to Improve Patient Outcomes," we share the personal story that's driven the rapid growth and success of Enveda Biosciences. The Boulder company harnesses artificial intelligence to discover drugs in nature.   Enveda Biosciences Founder & CEO Viswa Colluru, Ph.D., says the patient is at the center of everything his company does. "The defining emotion of a patient's journey is hope, and that's an effective medicine you can access."   Read more: https://lnkd.in/gT2QBCQq   #CoBioScience #StrongerTogether #InnovationForward #BuildingMomentum #ForgingLifeSciencesFrontier

"Right target, right patient, right disease" is a mantra that the team at Hummingbird Bioscience lives by. In this interview with CNA, Lisa Ooi, SVP of Strategy at Hummingbird Bioscience, breaks down why #precisionmedicine holds the potential for better results, lower cost, and could be a game changer for #publichealthcare delivery. Watch the full interview here: https://lnkd.in/ddxjE9BB Learn more about Hummingbird's bold new way of engineering precision biotherapeutics here: https://lnkd.in/geRkGGG

The data we recently presented at #ASH23 underscores the promise of our pipeline and differentiated research platforms, including #ProteinDegradation and #CARTcelltherapy. We will continue to invest in R&D and drive breakthrough science in hopes of putting more patients on the path to a cure. Learn more about our latest innovations. #BMS_Employee

The data we recently presented at #ASH23 underscores the promise of our pipeline and differentiated research platforms, including #ProteinDegradation and #CARTcelltherapy. We will continue to invest in R&D and drive breakthrough science in hopes of putting more patients on the path to a cure. Learn more about our latest innovations. #BMS_Employee

Learn more about how innovations developed at VCU, W&M, and ODU were transferred to businesses to turn into reality. Fascinating.

San Diego life science community, get ready to learn about the future of anti-aging technology! Join LaunchBio Inc. and Nucleate San Diego on April 11th for our next Larger Than Life Science event. This event will feature Dr. Anthony Molina, Daniel Oliver, and David H. Crean, with discussion led by Rubén Darío Flores Saaib who will explore the emerging field of anti-aging and the revolutionary technologies employed to both understand and address the aging process. Learn what is driving innovation, the opportunities for biotech start-ups, the investment trends shaping the sector, and the ethical and social implications of this technology. This is an excellent opportunity to connect with like-minded professionals and stay ahead of the curve in the life sciences industry. Register now and join us for an exciting evening of innovation and investment trends. Don't miss out on this chance to learn from industry leaders and explore the latest breakthroughs in biotech startups and longevity. Register Here: https://lnkd.in/gpiETiUU #LargerThanLifeScience #AntiAging #LifeSciences #Innovation #BiotechStartups #InvestmentTrends #Longevity

I'm Klaus Skaalum Lassen from #Novonesis, and I'm excited to be part of the "Crossing Chasms with Creative Capital" panel at SynBioBeta 2024. Join us on May 7th, from 2:45 to 3:30 pm, as we discuss the complexities and innovations of funding in the biotech sector. Alongside Tara Shirvani from Terrain Investing, Mary Maxon of Schmidt Sciences, Douglas Freidman from BioMADE, and John Nicols of Oranicols, we'll explore how creative financial strategies can bridge the gap between pioneering scientific research and market-ready biotech solutions. In this session, we’ll examine the latest trends and challenges in biotech financing, discussing how companies can secure the capital necessary to scale innovations and bring transformative biotechnologies to market. We'll share insights on leveraging a variety of funding mechanisms—from venture capital to public-private partnerships—that support the dynamic needs of biotech startups and established firms alike. Whether you’re an entrepreneur seeking funding, an investor looking for opportunities, or a biotech professional interested in the financial landscape, this workshop will provide valuable perspectives on navigating the intricacies of biotech investment. Join us for a comprehensive discussion on how innovative capital deployment can catalyze the growth and success of the biotech industry. #SynBioBeta2024 https://lnkd.in/dnSYyvBP 

Unlocking the Future of Longevity: Sam Altman's Investment in Rétro Biosciences 🚀 You may have missed the announcement from a few months ago: Sam Altman made a strategic investment in Retro Biosciences, a company revolutionizing longevity research and biotechnology. He invested $180M in the most secretive lab of the world. Rétro Biosciences' approach to understanding and combating age-related decline couldn't be more timely or essential. By harnessing cutting-edge technologies and AI, many biotechnologies are well positioned to developing ground-breaking therapies faster and more efficiently than ever before and make a profound impact on human health and well-being. The race for longevity and aging well has just started. Other companies, such as UNITY Biotechnology and Juvenescence®, are also joining this exciting journey. With AI driving innovation in this field, the future of longevity and quality of life looks brighter than ever. #Longevity #Innovation #Biotechnology #AI #Healthcare #Investment #health #healthcare #venturecapital #Biotech #diversityandinclusion #longevity #senior #ageism #life #purpose #motivation #pharma

The data we recently presented at #ASH23 underscores the promise of our pipeline and differentiated research platforms, including #ProteinDegradation and #CARTcelltherapy. We will continue to invest in R&D and drive breakthrough science in hopes of putting more patients on the path to a cure. Learn more about our latest innovations. #BMS_Employee